Some Analysts Just Cut Their Sigma Lithium Corporation (NASDAQ:SGML) Estimates
One thing we could say about the analysts on Sigma Lithium Corporation (NASDAQ:SGML) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
Following the downgrade, the most recent consensus for Sigma Lithium from its four analysts is for revenues of CA$244m in 2025 which, if met, would be a decent 11% increase on its sales over the past 12 months. Before the latest update, the analysts were foreseeing CA$266m of revenue in 2025. It looks like the analysts have become a bit less bullish on Sigma Lithium, given the slight decrease in revenue estimates after the latest consensus updates.
View our latest analysis for Sigma Lithium
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that Sigma Lithium's revenue growth is expected to slow, with the forecast 16% annualised growth rate until the end of 2025 being well below the historical 79% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 4.6% annually. Even after the forecast slowdown in growth, it seems obvious that Sigma Lithium is also expected to grow faster than the wider industry.
The clear low-light was that analysts slashing their revenue forecasts for Sigma Lithium this year. The analysts also expect revenues to grow faster than the wider market. Often, one downgrade can set off a daisy-chain of cuts, especially if an industry is in decline. So we wouldn't be surprised if the market became a lot more cautious on Sigma Lithium after today.
Hungry for more information? We have estimates for Sigma Lithium from its four analysts out until 2027, and you can see them free on our platform here.
Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
The "Magnificent Seven" Are Still Growing Faster Than the Rest of the S&P 500. Here's When That Could Change, According to Wall Street Analysts.
The "Magnificent Seven" produced far better earnings growth than the rest of the market in the first quarter. Amazon and Alphabet were the biggest contributors to the outperformance. Investors will have to consider valuation as the rest of the market catches up with the Magnificent Seven. 10 stocks we like better than Nvidia › The S&P 500 (SNPINDEX: ^GSPC) has produced phenomenal returns over the last two and a half years since the bottom of the 2022 bear market. The index is up nearly 70% since Oct. 2022, but much of that gain has been driven by just a handful of stocks. The "Magnificent Seven" have, for the most part, outperformed the benchmark over that period, and there's a clear reason why. As a group, the Magnificent Seven have produced much better earnings growth than the rest of the S&P 500. Not only that, they've consistently beaten high earnings expectations. That trend continued in the first quarter, but analysts are starting to think their phenomenal run of outperforming everything else in the market may come to an end soon. Here's what investors need to know. After Nvidia (NASDAQ: NVDA) released its quarterly earnings on May 28, FactSet reported the Magnificent Seven grew earnings 27.7% in aggregate. That massively outperformed analysts' expectations of 16.0% earnings growth for the group. Here's how it breaks down: Amazon (NASDAQ: AMZN): $1.59 earnings per share (EPS) vs. $1.36 expected, up 62% year over year. Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL): $2.81 EPS vs. $2.01 expected, up 49% year over year. Meta Platforms: $6.43 EPS vs. $5.22 expected, up 37% year over year. Nvidia: $0.81 EPS vs. $0.75 expected, up 33% year over year. Microsoft: $3.46 EPS vs. $3.22 expected, up 18% year over year. Apple: $1.65 EPS vs. $1.62 expected, up 8% year over year. Tesla (NASDAQ: TSLA): $0.27 EPS vs. $0.41 expected, down 40% year over year. Six out of the seven outperformed expectations, and five of them grew earnings faster than the other 493 companies in the S&P 500 (9.4%). But as you can see, the level of outperformance and year-over-year growth varies widely from company to company. The weakest showing was most obviously from Tesla, which has suffered from political backlash against CEO Elon Musk, combined with rising competition from Chinese automaker BYD. As a result, deliveries dropped 13% year over year in the first quarter while average selling price also declined. The company's ramp-up in AI spending to support its forthcoming autonomous vehicle efforts also weighed on earnings results. On the other side of the spectrum, Amazon and Alphabet exhibited impressive earnings growth on the back of their cloud-computing businesses. Amazon Web Services grew sales 17% year over year, while its margin expanded to 39.5% (up from 37.6% a year ago). Google Cloud grew sales 28% with its operating margin expanding to 17.8% from 9.4% a year ago. The high-margin Google advertising business continued to produce strong growth as well. Nvidia felt the pain of restrictions on sales of its GPUs to China, but the company still managed to produce very strong earnings growth last quarter. Without the impact of the write-off in excess inventory and purchase obligations of its H20 GPUs designed for China and the related tax impact, earnings growth would have been 57% . Though Tesla is the only one showing weakness at the moment, the rest of the group's outperformance isn't going to last forever. While analysts expect the group to continue beating the rest of the market in terms of earnings growth through the end of 2025, difficult comparisons and better performance among the rest of the stocks in the S&P 500 could present a challenge for 2026. As such, analysts currently forecast first-quarter 2026 earnings growth of 10.2% for the Magnificent Seven as a group, but the rest of the 493 companies will generate an average of 10.3% earnings growth. That forecast has some important implications for investors, even if it ultimately proves inaccurate (as is almost always the case for forecasts a year out). The first is investors will need to be more discriminating among the seven stocks going forward. We've already seen Tesla stock falter, and Apple, despite beating expectations, has seen its stock hit hard by tariff pressure. Even if investors expect strong results from one of the businesses going forward, valuation will matter more as earnings growth slows down. Alphabet is currently the only member of the group with a forward price-to-earnings ratio below 25 (it sports an extremely attractive 18.5x multiple). The second is that there may be a lot more growth opportunities among the smaller members of the S&P 500. While analysts expect growth for the group to continue trailing the Magnificent Seven through the end of the year, that won't be true of every company. It's possible to find those companies trading at a fair value despite strong growth prospects outside of the Magnificent Seven. Another option is to buy an equal-weight S&P 500 index fund like the Invesco S&P 500 Equal Weight ETF (NYSEMKT: RSP). The fund invests evenly across all 500 constituents of the S&P 500, rebalancing on a quarterly basis. That ensures you capture just as much upside from smaller businesses as you do from the biggest companies in the index. As the tide turns and we start to see more parity in the market, investors should expect a stronger showing over the next year (or longer) from smaller names in the stock market. Meanwhile, many of the Magnificent Seven are starting to look expensive relative to their future earnings growth prospects as analysts' expectations come down. It may be worth selling off some to invest in new opportunities. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor's total average return is 988% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Adam Levy has positions in Alphabet, Amazon, Apple, Meta Platforms, and Microsoft. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Nvidia, and Tesla. The Motley Fool recommends BYD Company and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. The "Magnificent Seven" Are Still Growing Faster Than the Rest of the S&P 500. Here's When That Could Change, According to Wall Street Analysts. was originally published by The Motley Fool
Associated Press
38 minutes ago
- Associated Press
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Current Investigation Into Compass Diversified Holdings (NYSE: CODI)
NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), a shareholder and consumer rights litigation firm, is investigating whether Compass Diversified Holdings ('Compass' or the 'Company') (NYSE: CODI) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Compass owns and manages a diverse set of middle-market businesses, including Lugano Holdings, Inc. ('Lugano'), which designs, manufacturers, and markets luxury jewelry. On May 7, 2025, after market hours, the Company issued a press release disclaiming 'reliance on its financial statements for fiscal 2024 amid an ongoing internal investigation' into Lugano, and that the Company intends to delay the filing of its 1Q25 Form 10-Q. The press release also revealed that an ongoing investigation, led by outside counsel and a forensic accounting firm, 'preliminarily identified irregularities in Lugano's [non-Compass] financing, accounting, and inventory practices.' Lugano's founder and Chief Executive Officer resigned following the disclosure of the investigation's preliminary findings. On this news, the price of the Company's stock fell $10.70, or nearly 62%, to close at $6.55 on May 8, 2025, on unusually high volume ARE YOU A POTENTIAL CLASS MEMBER ELIGIBLE TO RECOVER? CLICK HERE If you purchased or otherwise own Compass securities and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Nicholas Bruno at (888) 398-9312 or at [email protected]. CLICK HERE TO FIND OUT IF YOU CAN RECOVER YOUR LOSSES About Scott+Scott Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. This may be considered Attorney Advertising. CONTACT: Nicholas Bruno Scott+Scott Attorneys at Law LLP 230 Park Avenue, 24th Floor, New York, NY 10169 (888) 398-9312 [email protected]
Associated Press
38 minutes ago
- Associated Press
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - June 14, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the 'Class Period'), of the important July 22, 2025 lead plaintiff deadline. SO WHAT: If you purchased Organon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Organon class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 22, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Organon's priorities, particularly, related to capital allocation through quarterly dividends. Notably, defendants concealed the high priority of Organon's debt reduction strategy following Organon's acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Organon class action, go to call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
